Avelumab first-line maintenance for advanced or metastatic urothelial carcinoma: analysis from JAVELIN Bladder 100 trial

Transl Androl Urol. 2024 Jul 31;13(7):1327-1328. doi: 10.21037/tau-24-16. Epub 2024 Jun 25.

Authors

Srigita Madiraju¹, Firas G Petros¹

Affiliation

¹ Department of Urology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, USA.

No abstract available

Keywords: Avelumab; JAVELIN; bladder cancer; maintenance; urothelial carcinoma (UC).

Publication types

Editorial
Comment